Jaguar Health Inc. [NASDAQ: JAGX] traded at a low on 07/31/20, posting a -2.42 loss after which it closed the day’ session at $0.65. The company report on July 22, 2020 that Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) announced today that effective June 16, 2020, the Company has granted nonstatutory stock options for the purchase of up to 30,000 shares of the Company’s common stock to one new employee as inducement awards under the Company’s Inducement Award Plan. The nonstatutory stock options were granted as an inducement material to the new employee’s acceptance of employment with the Company and were approved by the Compensation Committee of the Board. The nonstatutory stock options have an exercise price of $0.6961 per share, representing the closing price of Jaguar’s common stock as reported by Nasdaq on the grant date. The nonstatutory stock option award has a 10-year term and vests 25% at nine (9) months from the last day of the month of the employee’s date of hire, and vests monthly thereafter for the remaining twenty-seven (27) months. Vesting of the nonstatutory stock option is subject to the employee’s continued service with Jaguar through the applicable vesting dates.
About Jaguar Health, Inc.
The results of the trading session contributed to over 2815491 shares changing hands. Over the past one week, the price volatility of Jaguar Health Inc. stands at 8.92% while the volatility over the past one month is 12.97%.
The market cap for JAGX stock reached $21.60 million, with 32.16 million shares outstanding and 16.07 million shares in the current float. Compared to the average trading volume of 4.84M shares, JAGX reached a trading volume of 2815491 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Jaguar Health Inc. [JAGX]?
Rodman & Renshaw have made an estimate for Jaguar Health Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 11, 2017.
The Average True Range (ATR) for Jaguar Health Inc. is set at 0.07, with the Price to Sales ratio for JAGX stock in the period of the last 12 months amounting to 4.23. The Price to Book ratio for the last quarter was 2.04, with the Price to Cash per share for the same quarter was set at 0.04.
How has JAGX stock performed recently?
Jaguar Health Inc. [JAGX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.33. With this latest performance, JAGX shares gained by 36.01% in over the last four-week period, additionally sinking by -14.85% over the last 6 months – not to mention a drop of -59.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JAGX stock in for the last two-week period is set at 53.75, with the RSI for the last a single of trading hit 47.96, and the three-weeks RSI is set at 54.21 for Jaguar Health Inc. [JAGX]. The present Moving Average for the last 50 days of trading for this stock 0.5632, while it was recorded at 0.6771 for the last single week of trading, and 0.6095 for the last 200 days.
Jaguar Health Inc. [JAGX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Jaguar Health Inc. [JAGX] shares currently have an operating margin of -420.75 and a Gross Margin at +33.93. Jaguar Health Inc.’s Net Margin is presently recorded at -667.32.
Return on Total Capital for JAGX is now -82.93, given the latest momentum, and Return on Invested Capital for the company is -217.73. Return on Equity for this stock declined to -220.53, with Return on Assets sitting at -99.52. When it comes to the capital structure of this company, Jaguar Health Inc. [JAGX] has a Total Debt to Total Equity ratio set at 36.78. Additionally, JAGX Total Debt to Total Capital is recorded at 26.89, with Total Debt to Total Assets ending up at 20.78. Long-Term Debt to Equity for the company is recorded at 5.02, with the Long-Term Debt to Total Capital now at 1.60.
Reflecting on the efficiency of the workforce at the company, Jaguar Health Inc. [JAGX] managed to generate an average of -$1,328,946 per employee. Receivables Turnover for the company is 4.28 with a Total Asset Turnover recorded at a value of 0.15.Jaguar Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.40.
Earnings analysis for Jaguar Health Inc. [JAGX]
With the latest financial reports released by the company, Jaguar Health Inc. posted -12.6/share EPS, while the average EPS was predicted by analysts to be reported at -13.3/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 5.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JAGX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Jaguar Health Inc. go to 40.00%.
Insider trade positions for Jaguar Health Inc. [JAGX]
There are presently around $0 million, or 3.40% of JAGX stock, in the hands of institutional investors. The top three institutional holders of JAGX stocks are: VIRTU FINANCIAL LLC with ownership of 105,891, which is approximately New of the company’s market cap and around 10.37% of the total institutional ownership; VANGUARD GROUP INC, holding 30,283 shares of the stock with an approximate value of $20000.0 in JAGX stocks shares; and UBS GROUP AG, currently with $19000.0 in JAGX stock with ownership of nearly New of the company’s market capitalization.
Positions in Jaguar Health Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 7 institutional holders increased their position in Jaguar Health Inc. [NASDAQ:JAGX] by around 175,847 shares. Additionally, 2 investors decreased positions by around 81,075 shares, while 5 investors held positions by with 7,896 shares. The mentioned changes placed institutional holdings at 249,026 shares, according to the latest SEC report filing. JAGX stock had 6 new institutional investments in for a total of 175,764 shares, while 2 institutional investors sold positions of 81,075 shares during the same period.